Cephea South America Feasibility Study
NCT: NCT07244939 · ACTIVE_NOT_RECRUITING
Brief Summary
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
Frequently Asked Questions
What is Cephea South America Feasibility Study?
Cephea South America Feasibility Study is a clinical trial registered under NCT07244939. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07244939?
The current status of NCT07244939 (Cephea South America Feasibility Study) is: ACTIVE_NOT_RECRUITING.
When did Cephea South America Feasibility Study start?
Cephea South America Feasibility Study started on 2025-06-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.